A feasibility study of octreotide infusion during liver transplant

Not Applicable

Completed

• Conditions: Perioperative bleeding, liver transplant; Surgery

• Registration Number: ISRCTN17573492
• Lead Sponsor: niversity College London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-05
• Study Completion: 2023-10-31
• Last Update Posted: 29 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Aged =18 years
2. Undergoing primary liver transplantation of a whole or partial liver graft from a cardiac or brain dead donor
3. Provision of written informed consent

Exclusion Criteria

1. Previous solid organ transplant
2. Acute liver failure
3. Fulminant hepatic failure
4. Patients receiving a living donor liver graft
5. Patients currently admitted to ICU prior to transplantation
6. Requirement of haemodialysis or Continuous Veno-Venous Hemofiltration (CVVHF) pre-operatively
7. Known allergy or adverse reaction to octreotide
8. Pre-operative decision to use intra-operative CVVHF
9. A positive pregnancy test

Study & Design

• Study Type: Interventional
• Study Design: Not specified